We therefore propose that EWS/FLI, through upregulation of NKX2-2, and ZEB2 act to repress differentiation in opposite directions along the epithelial-mesenchymal spectrum; together, they maintain Ewing sarcoma cells in a partially differentiated state. The gene discussed is ZEB2; the disease is Ewing sarcoma.